COVID-19: Caring for Patients and Communities
AONL joined with other organizations concerned about the health and well-being of mothers, infants and families to urge Congress to invest in national surveillance of COVID-19’s impact on maternal and infant health.
Remdesivir, an experimental drug found useful in shortening the duration of COVID-19, is being allocated to those regions hardest hit by the pandemic.
In response to the pandemic, opportunities to learn about timely topics are now widely available at no cost. On May 18, the Johns Hopkins School of Nursing will begin a two-week course for nurses on how to provide high quality care during a time of low resources and high uncertainty.
A recent advisory from the American Hospital Association (AHA) compiles useful information on maternal and neonatal practices during COVID-19 from government agencies, academic institutions, professional associations and health care organizations.
In an essay on the changes that may occur in health care as a result of the current pandemic, Donald Berwick, MD, president emeritus and senior fellow at the Institute for Healthcare Improvement, lists choices decision-makers face today as they shape the future of health care.
In a May 7 letter to the White House, Ernest Grant, PhD, RN, president of the American Nurses Association (ANA), thanked President Trump for recognizing nurses’ contributions on the front lines of COVID-19 and urged him to appoint a nurse to the Coronavirus Task Force.